ANKRD22-IN-1 is a potent inhibitor of ANKRD22. ANKRD22-IN-1 promotes the expansion of gastrointestinal mucosal epithelial stem cells and indirectly activates the Wnt classical pathway, which helps the recovery of damaged gastrointestinal mucosal tissues in the body (extracted from patent CN111205231B)[1].
[1]. Yongquan Zhu, et al. Lead compounds as ankrd22 inhibitors and their applications. Patent CN111205231B.
















